Coastal Infusion Administers Stelara IV®

Stelara IV (ustekinumab) are used for the treatment of various autoimmune diseases such as psoriatic arthritis, plaque psoriasis, and ulcerative colitis. It works by targeting a protein called interleukin-12 (IL-12) and interleukin-23 (IL-23), which are involved in the inflammatory process of these diseases.

Ustekinumab, the active ingredient in Stelara, is a monoclonal antibody that targets specific proteins in the immune system, interleukin-12 (IL-12), and interleukin-23 (IL-23). These cytokines play crucial roles in regulating the body’s immune response.

By inhibiting the action of IL-12 and IL-23, Stelara helps modulate the inflammatory processes involved in autoimmune disorders, reducing symptoms and providing relief to patients.

What It Treats

• Plaque Psoriasis
• Psoriatic Arthritis
• Crohn’s Disease

Prescribed By

• Dermatologists
• Gastroenterologists
• Rheumatologists

How it’s Administered

Stelara IV is administered, initially, by intravenous infusion. Subsequent treatments are usually via subcutaneous injection. Stelara IV treatments take only a few minutes.

Frequency

Stelara IV is generally administered every 12 weeks after the starter dose.

Related Drugs

Ilumya, Omvoh, Skyrizi, Tremfya,

Additional Resources

• Stelara IV Website
• Prescribing Information
• Co-Pay Assistance

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies